This article summarizes clinical trial data for three new GLP-1 medications aimed at weight loss.
Discusses clinical trial data for injectable and pill formulations.
Highlights the review process by the US Food and Drug Administration (FDA).
The data indicates positive effects on weight loss among participants during trials.
The medications are currently awaiting approval for public use.
Abstract
This Medical News article discusses clinical trial data for weight-loss medications, in both injectable and pill formations, that are currently under review with US Food and Drug Administration.